Sara Sherman

Head of Investor Relations

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Sara Sherman

Sara Sherman is recorded as Head of Investor Relations at UroGen Pharma Ltd. (URGN). Sara Sherman has spoken on 2 earnings calls across 1 company, most recently for UroGen Pharma Ltd. on July 14, 2021.

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Sara Sherman's recent earnings-call comments and cite the source calls.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

UroGen Pharma Ltd. (URGN)
Head of Investor Relations

Source not stated

Current

Company network

Recorded roles and call appearances connecting this person to public companies.

UroGen Pharma Ltd.

URGN

Current role

Head of Investor Relations

2 appearances Latest appearance 2021-07-14

View calls and events

Leadership on record at UroGen Pharma Ltd.

Other people whose current roles at this company are on record from its filings.

Elizabeth Barrett CEO, Board Member
Arie Belldegrun Chairman, Board Member
Chris Degnan CFO
Dong (Don) Kim CFO
Stephen L. Mullennix COO
Jason Smith General Counsel
Christopher Degnan Chief Accounting Officer
Arie Belldegrun, M.D. Board Member
Arie Belldegrun, M.D., FACS Board Member
Cynthia M. Butitta Board Member

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Earnings call UroGen Pharma Ltd. Q2 FY2021 Earnings Call UroGen Pharma Ltd. (URGN)
2021-07-14
Earnings call UroGen Pharma Ltd. Q4 FY2020 Earnings Call UroGen Pharma Ltd. (URGN)
2021-03-18